IRIDEX Corp (IRIX): Market Cap to Revenue

Symbol and logo of brand IRIDEX Corp. (IRIX)

IRIDEX Corporation (IRIX) leads the ophthalmology sector thanks to MicroPulse, which ensures safe retinal treatment. However, a reduction in purchasing clinics and competition are slowing the transition to a consumables-based model. System assembly in California guarantees precision through the use of sterile zones. The company's rolling P/S ratio clearly demonstrates the market valuation of revenue, while 0.20 captures the current state of the parameter on the chart.

IRIX IRIDEX Corp. P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for IRIDEX Corporation (IRIX)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
General company analysis:IRIX IRIDEX Corp
Core merchandise of IRIDEX

Investors are assessing the potential of IRIDEX Corporation (IRIX) through the price-to-sales ratio, determining the value of every dollar of revenue. This multiple measures the market premium relative to the actual cash flow generated from laser system sales. Analyzing historical P/S levels helps identify valuation anomalies amid cost optimization driven by the outsourcing of housing components. The stability of this indicator confirms the business model's resilience to commodity shocks.

Competitors of IRIDEX Corporation

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corporation)|Price-to-Revenue Ratio Sensus Healthcare Corp|Market Cap to Revenue Zynex Corp (ZYXI)|P/S Multiple ECOR|RBOT - Price to Sales|Price-to-Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|PFSA: P/S Multiple|SSKN - Price-to-Revenue Coefficient|Price-to-Revenue Ratio GlucoTrack, Inc.|NAOV: Market Capitalization-to-Revenue Ratio|P/S Multiple VERO|Price-to-Revenue Coefficient Nuwellis Corp|P/S Multiple AEMD (Aethlon Medical)|ASXC: Market Cap to Revenue Ratio|Avinger - P/S Multiple|Price to Sales BioSig|CUTR (Cutera, Inc) - Market Cap to Revenue|Market Cap to Revenue Ratio KNW|Market Cap to Revenue NARI|NVRO: Market Capitalization-to-Revenue Ratio|P/S Multiple RSLS|Market Cap to Revenue Silk Road Medical, Inc. SILK